Total Payments
$2,861
2024 Payments
$400.53
Companies
17
Transactions
125
Medicare Patients
1,076
Medicare Billing
$94,261
Payment Breakdown by Category
Food & Beverage$2,833 (99.0%)
Other$28.30 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,833 | 123 | 99.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $28.30 | 2 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $458.62 | 31 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $419.32 | 27 | $0 (2019) |
| ABBVIE INC. | $378.98 | 5 | $0 (2024) |
| UCB, Inc. | $354.73 | 16 | $0 (2024) |
| Genentech USA, Inc. | $245.43 | 7 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $198.87 | 11 | $0 (2018) |
| Alexion Pharmaceuticals, Inc. | $149.79 | 7 | $0 (2019) |
| ACADIA Pharmaceuticals Inc | $116.81 | 1 | $0 (2017) |
| Lundbeck LLC | $114.61 | 2 | $0 (2017) |
| Eisai Inc. | $111.41 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $400.53 | 14 | UCB, Inc. ($168.53) |
| 2023 | $428.36 | 13 | AbbVie Inc. ($255.02) |
| 2022 | $59.51 | 3 | Amneal Pharmaceuticals LLC ($31.48) |
| 2021 | $57.26 | 4 | Biogen, Inc. ($44.88) |
| 2019 | $226.97 | 15 | Supernus Pharmaceuticals, Inc. ($189.74) |
| 2018 | $737.68 | 41 | Biogen, Inc. ($179.96) |
| 2017 | $950.81 | 35 | Biogen, Inc. ($201.72) |
All Payment Transactions
125 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: Neurology | ||||||
| 11/04/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $11.44 | General |
| Category: Neurology | ||||||
| 10/30/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $28.45 | General |
| Category: Neurology | ||||||
| 09/05/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $10.17 | General |
| Category: Neurology | ||||||
| 08/29/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $32.71 | General |
| Category: Neurology | ||||||
| 06/24/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $8.13 | General |
| Category: Neurology | ||||||
| 06/21/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Neurology | ||||||
| 06/11/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Neurology | ||||||
| 05/23/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: Neurology | ||||||
| 04/18/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $35.77 | General |
| Category: Neurology | ||||||
| 03/27/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Neurology | ||||||
| 03/21/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $40.90 | General |
| Category: Neurology | ||||||
| 02/06/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $26.07 | General |
| Category: Immunology | ||||||
| 01/30/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $123.96 | General |
| Category: NEUROSCIENCE | ||||||
| 12/20/2023 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Neurology | ||||||
| 11/09/2023 | AbbVie Inc. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $112.76 | General |
| Category: NEUROSCIENCE | ||||||
| 10/12/2023 | Genentech USA, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Immunology | ||||||
| 10/09/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Neurology | ||||||
| 10/09/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.41 | General |
| Category: NEUROSCIENCE | ||||||
| 07/26/2023 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: Neurology | ||||||
| 07/22/2023 | Genentech USA, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $25.75 | General |
| Category: Immunology | ||||||
| 06/29/2023 | Genentech USA, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: Immunology | ||||||
| 06/07/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $7.35 | General |
| Category: NEUROSCIENCE | ||||||
| 04/18/2023 | AbbVie Inc. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $123.50 | General |
| Category: NEUROSCIENCE | ||||||
| 04/12/2023 | Genentech USA, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 196 | 250 | $67,595 | $18,804 |
| 2022 | 6 | 217 | 264 | $62,124 | $18,162 |
| 2021 | 7 | 340 | 400 | $95,525 | $30,443 |
| 2020 | 7 | 323 | 385 | $96,259 | $26,852 |
Total Patients
1,076
Total Services
1,299
Medicare Billing
$94,261
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 73 | 113 | $22,826 | $7,009 | 30.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 38 | 47 | $14,006 | $4,092 | 29.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 34 | 34 | $15,504 | $3,601 | 23.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 21 | 21 | $7,980 | $2,141 | 26.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 17 | 17 | $5,083 | $1,197 | 23.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 13 | 18 | $2,196 | $763.74 | 34.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 87 | 127 | $24,198 | $7,052 | 29.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 35 | 35 | $15,118 | $4,165 | 27.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 31 | 36 | $10,272 | $3,519 | 34.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 27 | 27 | $7,548 | $2,033 | 26.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 24 | 26 | $2,942 | $752.38 | 25.6% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2022 | 13 | 13 | $2,046 | $640.31 | 31.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 107 | 147 | $27,342 | $9,434 | 34.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 47 | 47 | $19,433 | $5,956 | 30.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 56 | 70 | $19,180 | $5,888 | 30.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 66 | 66 | $18,105 | $5,703 | 31.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 20 | 21 | $7,329 | $2,165 | 29.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 31 | 36 | $4,032 | $1,262 | 31.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 13 | 13 | $104.00 | $36.00 | 34.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 98 | 137 | $25,482 | $6,992 | 27.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 54 | 54 | $22,236 | $6,326 | 28.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 62 | 82 | $22,424 | $6,086 | 27.1% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 51 | 51 | $14,025 | $3,804 | 27.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 20 | 20 | $6,980 | $2,336 | 33.5% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 25 | 28 | $3,136 | $685.29 | 21.9% |
About Dr. Jeffrey Rubin, M.D
Dr. Jeffrey Rubin, M.D is a Neurology healthcare provider based in West Palm Beach, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1730280942.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Rubin, M.D has received a total of $2,861 in payments from pharmaceutical and medical device companies, with $400.53 received in 2024. These payments were reported across 125 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($2,833).
As a Medicare-enrolled provider, Rubin has provided services to 1,076 Medicare beneficiaries, totaling 1,299 services with total Medicare billing of $94,261. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location West Palm Beach, FL
- Active Since 09/26/2006
- Last Updated 05/18/2017
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1730280942
Products in Payments
- TROKENDI XR (Drug) $407.55
- QULIPTA (Drug) $360.22
- Briviact (Drug) $294.65
- TYSABRI (Biological) $263.69
- APTIOM (Drug) $198.87
- Ocrevus (Biological) $133.25
- SOLIRIS (Drug) $126.28
- NUPLAZID (Drug) $116.81
- OCREVUS (Biological) $112.18
- Fycompa (Drug) $111.41
- ONFI (Drug) $109.77
- AUBAGIO (Drug) $108.48
- KESIMPTA (Drug) $99.73
- TECFIDERA (Drug) $72.44
- Vimpat (Drug) $36.07
- RYTARY (Drug) $31.48
- AMPYRA (Drug) $28.30
- Fintepla (Drug) $24.01
- Rebif (Biological) $18.77
- UBRELVY (Drug) $18.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in West Palm Beach
Nisha Chhabria, Md, MD
Neurology — Payments: $267,525
Neurology $267,525
Arnaldo Da Silva, Md, MD
Neurology — Payments: $189,267
Neurology $189,267
Ali Malek, M.d, M.D
Neurology — Payments: $170,038
Neurology $170,038
Pedro Hernandez-Frau, M.d, M.D
Neurology — Payments: $61,313
Neurology $61,313
Carl Sadowsky, Md, MD
Neurology — Payments: $57,814
Neurology $57,814
Ms. Paayal Patel, M.d, M.D
Neurology — Payments: $34,817
Neurology $34,817